Semi-Annual Statement Of Income And Retained Earnings

Chordia Therapeutics,Inc - Filing #7339264

Concept 2023-09-01 to
2024-02-29
2022-09-01 to
2023-08-31
2022-09-01 to
2023-08-31
2022-09-01 to
2023-08-31
2022-09-01 to
2023-08-31
2021-09-01 to
2022-08-31
2021-09-01 to
2022-08-31
2021-09-01 to
2022-08-31
2021-09-01 to
2022-08-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-809,656,000 JPY
212,057,000 JPY
-1,844,116,000 JPY
Non-operating income
Non-operating income
11,444,000 JPY
25,948,000 JPY
94,970,000 JPY
Non-operating expenses
Non-operating expenses
3,189,000 JPY
12,243,000 JPY
27,495,000 JPY
Ordinary profit (loss)
-801,401,000 JPY
225,761,000 JPY
-1,776,640,000 JPY
Profit (loss) before income taxes
-801,401,000 JPY
225,761,000 JPY
-1,776,640,000 JPY
Income taxes - current
1,210,000 JPY
2,420,000 JPY
2,420,000 JPY
Profit (loss)
-802,611,000 JPY
223,341,000 JPY
223,341,000 JPY
223,341,000 JPY
223,341,000 JPY
-1,779,060,000 JPY
-1,779,060,000 JPY
-1,779,060,000 JPY
-1,779,060,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.